from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2441c/rpmA

LFCtreatmentdescriptionclass of inhibitor

2.080

Amikacinug/mL Amikacintranslation

1.838

Cap5-10ug/mL Capreomycintranslation

2.200

Rox10-50 ug/mL Roxithromycintranslation

1.206

SM2-5 ug/mL Streptomycintranslation

1.724

Tet5-10 ug/mL Tetracyclinetranslation

-0.865

Rif0.2-5ug/mL Rifampicintranscription

-0.426

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.417

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.884

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.154

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.367

Clofazimine10-13 ug/mL Clofaziminerespiration

0.434

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.339

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.471

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.578

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.242

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.049

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.402

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.648

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.521

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.143

KCN5-20 ug/mL Potassium cyaniderespiration

-0.526

NaN30.2-2 mM Sodium aziderespiration

0.183

Nigericin50 uM Nigericinrespiration

-1.592

TRC10-150 ug/mL Triclosanrespiration

-0.808

TRZ10-25 ug/mL Thioridazinerespiration

1.045

Valinomycin0.5-10 uM Valinomycinrespiration

0.064

ZnSO42 mM ZnSO4respiration

0.514

menadione6-10 ug/mL Menadionerespiration

0.085

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.407

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.411

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.369

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.075

NRP_1Non-replicating persistence stage 1dosRassociated

0.553

Amp0.2mg/mL AmpicillincellWall

0.238

Cephalexin20-100 ug/mL CephalexincellWall

0.589

Cerulenin0.32-5 ug/mL CerulenincellWall

0.649

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.106

EMB10-20 ug/mL EthambutolcellWall

0.302

Eta12-40 ug/mL EthionamidecellWall

0.409

INH0.2-0.4 ug/mL IsoniazidcellWall

0.343

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.146

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.653

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.678

BZA0.12 mg/mL BenzamidearomaticAmides

-0.272

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.217

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.319

H2O24 mM hydrogen peroxideDNAdamaging

0.596

Levo10 ug/mL LevofloxacinDNAdamaging

0.650

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.320

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.546

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.707

UVUV-irradiationDNAdamaging

-1.214

ARP41-4 ug/mL Antitubercular compound ARP4?

0.461

Antimycin12.5-50 ug/mL Antimycin A?

0.431

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.459

PA_110-50 ug/mL Antitubercular compound PA-1?

0.528

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.256

PA8240.2-2 ug/mL PA-824?

-1.449

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.347

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.407

Verapamil50 uM Verapamil?

0.265

mercaptoethanol2 mM 2-Mercaptoethanol?

0.311

methoxatin10-20 ug/mL Methoxatin?